$20.24
0.10.50%
Pre-Market: 4:03 AM EDT
Comments
Loading...
Genmab Stock Guidance | NASDAQ:GMAB | Benzinga
Genmab issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/12/2025 | GMAB | Genmab | FY | 2025 | — | — | — | $3.34B | $3.66B | $3.51B | Get Alert |
| 11/06/2024 | GMAB | Genmab | FY | 2024 | — | — | — | $3.11B | $3.20B | $3.08B | Get Alert |
| 08/08/2024 | GMAB | Genmab | FY | 2024 | — | — | — | $2.96B | $3.13B | $2.89B | Get Alert |
| 05/02/2024 | GMAB | Genmab | FY | 2024 | — | — | — | $2.72B | $2.98B | $2.84B | Get Alert |
| 02/14/2024 | GMAB | Genmab | FY | 2024 | — | — | — | $2.70B | $2.96B | $2.76B | Get Alert |
| 11/07/2023 | GMAB | Genmab | FY | 2023 | — | — | — | $2.32B | $2.41B | $2.30B | Get Alert |
| 07/28/2023 | GMAB | Genmab | FY | 2023 | — | — | — | $2.27B | $2.41B | $2.38B | Get Alert |
| 05/10/2023 | GMAB | Genmab | FY | 2023 | — | — | — | $1.94B | $2.13B | $2.31B | Get Alert |
| 02/22/2023 | GMAB | Genmab | FY | 2023 | — | — | — | $1.94B | $2.13B | $2.44B | Get Alert |
| 11/09/2022 | GMAB | Genmab | FY | 2022 | — | — | — | $1.83B | $1.97B | $1.72B | Get Alert |
| 11/03/2022 | GMAB | Genmab | FY | 2022 | — | — | — | $1.88B | $2.01B | $1.68B | Get Alert |
| 08/10/2022 | GMAB | Genmab | FY | 2022 | — | — | — | $1.72B | $1.86B | — | Get Alert |
| 08/08/2022 | GMAB | Genmab | FY | 2022 | — | — | — | $1.72B | $1.86B | — | Get Alert |
| 05/11/2022 | GMAB | Genmab | FY | 2022 | — | — | — | $1.66B | $1.81B | — | Get Alert |
| 02/16/2022 | GMAB | Genmab | FY | 2022 | — | — | — | $1.66B | $1.85B | $1.68B | Get Alert |
| 11/10/2021 | GMAB | Genmab | FY | 2021 | — | — | — | $1.32B | $1.42B | $1.27B | Get Alert |
| 11/04/2021 | GMAB | Genmab | FY | 2021 | — | — | — | $1.25B | $1.35B | $1.27B | Get Alert |
| 08/11/2021 | GMAB | Genmab | FY | 2021 | — | — | — | $1.18B | $1.28B | $1.27B | Get Alert |
| 02/23/2021 | GMAB | Genmab | FY | 2021 | — | — | — | $1.09B | $1.20B | $1.30B | Get Alert |
| 11/04/2020 | GMAB | Genmab | FY | 2020 | — | — | — | $1.45B | $1.55B | $1.52B | Get Alert |
| 08/12/2020 | GMAB | Genmab | FY | 2020 | — | — | — | $1.34B | $1.43B | $1.33B | Get Alert |
FAQ
What is the most recent guidance for Genmab (GMAB)?
There have been no specific sales or earnings guidance reported for Genmab in recent months.
Browse guidance and forecast on all stocks.